Pacer Advisors’s Calumet Specialty Products CLMT Stock Holding History

Pacer Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,923	Closed	-$100K	–	1198
2017 Q3	$100K	Hold	11,923	–	–	0.01%	1060
2017 Q2	$50K	Hold	11,923	–	–	﹤0.01%	1115
2017 Q1	$45K	Hold	11,923	–	–	0.01%	1043
2016 Q4	$48K	Buy	+11,923	New	+$48.6K	0.01%	1031

Other funds holding CLMT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SPCM

Sound Point Capital Management New York $28.3M AUM 13.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Pacer Advisors's CLMT Position: Q4 2017 in Review

Pacer Advisors sold out of Calumet Specialty Products (CLMT) in Q4 2017, closing a stake of 11,923 shares — an estimated $100K sold.

Pacer Advisors first reported a position in CLMT in Q4 2016 and held it in 4 quarters. The position peaked at $100K in Q3 2017. 73 funds tracked by Wall St. Rank hold CLMT as of Q4 2017.

Pacer Advisors reported no remaining Calumet Specialty Products position as of Q4 2017 after selling out during the quarter.
Pacer Advisors sold 11,923 Calumet Specialty Products shares in Q4 2017, an estimated $100K.
Pacer Advisors first reported a position in Calumet Specialty Products in Q4 2016 and held it in 4 quarters.
Pacer Advisors's Calumet Specialty Products position peaked at $100K in Q3 2017.
73 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2017.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.